These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2121 related articles for article (PubMed ID: 26034368)
21. Conceptual models for the initiation of hepatitis B virus-associated hepatocellular carcinoma. Tu T; Budzinska MA; Shackel NA; Jilbert AR Liver Int; 2015 Jul; 35(7):1786-800. PubMed ID: 25640596 [TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122. Liang HW; Wang N; Wang Y; Wang F; Fu Z; Yan X; Zhu H; Diao W; Ding Y; Chen X; Zhang CY; Zen K J Hepatol; 2016 Feb; 64(2):278-291. PubMed ID: 26409216 [TBL] [Abstract][Full Text] [Related]
23. [The Evaluation Value of Methylation Status of CpG Island of SFRP1 and LINE1 Gene Promoter Area in the Prognosis of Hepatocellular Carcinoma.]. Huang Y; Wei L; Sun AM; Zhao RC; Zhang J; Yang HT; Li B; Sun CJ; Ding XQ; Gao B; Zhong YQ; Qin Y Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):883-888. PubMed ID: 28598118 [TBL] [Abstract][Full Text] [Related]
24. Zinc finger transcription factor 191, directly binding to β-catenin promoter, promotes cell proliferation of hepatocellular carcinoma. Liu G; Jiang S; Wang C; Jiang W; Liu Z; Liu C; Saiyin H; Yang X; Shen S; Jiang D; Zhou P; Han D; Hu X; Yi Q; Yu L Hepatology; 2012 Jun; 55(6):1830-9. PubMed ID: 22213192 [TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic characteristics of Wnt/β-catenin-deregulated hepatocellular carcinoma. Verma A; Bal M; Ramadwar M; Deodhar K; Patil P; Goel M Indian J Cancer; 2017; 54(4):634-639. PubMed ID: 30082549 [TBL] [Abstract][Full Text] [Related]
26. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma. Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186 [TBL] [Abstract][Full Text] [Related]
27. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway. Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806 [TBL] [Abstract][Full Text] [Related]
28. Aberrant regulation of Wnt signaling in hepatocellular carcinoma. Liu LJ; Xie SX; Chen YT; Xue JL; Zhang CJ; Zhu F World J Gastroenterol; 2016 Sep; 22(33):7486-99. PubMed ID: 27672271 [TBL] [Abstract][Full Text] [Related]
29. Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib. Lachenmayer A; Alsinet C; Savic R; Cabellos L; Toffanin S; Hoshida Y; Villanueva A; Minguez B; Newell P; Tsai HW; Barretina J; Thung S; Ward SC; Bruix J; Mazzaferro V; Schwartz M; Friedman SL; Llovet JM Clin Cancer Res; 2012 Sep; 18(18):4997-5007. PubMed ID: 22811581 [TBL] [Abstract][Full Text] [Related]
30. Antiproliferative Effects of Epigenetic Modifier Drugs Through E-cadherin Up-regulation in Liver Cancer Cell Lines. Uribe D; Cardona A; Esposti DD; Cros MP; Cuenin C; Herceg Z; Camargo M; Cortés-Mancera FM Ann Hepatol; 2018; 17(3):444-460. PubMed ID: 29735783 [TBL] [Abstract][Full Text] [Related]
31. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis. Zhu R; Mok MT; Kang W; Lau SS; Yip WK; Chen Y; Lai PB; Wong VW; To KF; Sung JJ; Cheng AS; Chan HL J Pathol; 2015 Sep; 237(1):38-49. PubMed ID: 25925944 [TBL] [Abstract][Full Text] [Related]
32. A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines. Shi Y; Wang J; Wang Y; Wang A; Guo H; Wei F; Mehta SR; Espitia S; Smith DM; Liu L; Zhang Y; Chen D Cancer Lett; 2016 Feb; 371(2):285-91. PubMed ID: 26706415 [TBL] [Abstract][Full Text] [Related]
33. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Hussain SP; Schwank J; Staib F; Wang XW; Harris CC Oncogene; 2007 Apr; 26(15):2166-76. PubMed ID: 17401425 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of hepatitis-B-virus core promoter by p53: implications for carcinogenesis in hepatocytes. Uchida T; Takahashi K; Tatsuno K; Dhingra U; Eliason JF Int J Cancer; 1996 Sep; 67(6):892-7. PubMed ID: 8824564 [TBL] [Abstract][Full Text] [Related]
35. Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation. Qiu X; Zhang L; Lu S; Song Y; Lao Y; Hu J; Fan H Oncol Rep; 2014 Jan; 31(1):202-8. PubMed ID: 24247422 [TBL] [Abstract][Full Text] [Related]
36. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma]. Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828 [TBL] [Abstract][Full Text] [Related]
38. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma. Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071 [TBL] [Abstract][Full Text] [Related]
39. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Boyault S; Rickman DS; de Reyniès A; Balabaud C; Rebouissou S; Jeannot E; Hérault A; Saric J; Belghiti J; Franco D; Bioulac-Sage P; Laurent-Puig P; Zucman-Rossi J Hepatology; 2007 Jan; 45(1):42-52. PubMed ID: 17187432 [TBL] [Abstract][Full Text] [Related]
40. Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis. Um TH; Kim H; Oh BK; Kim MS; Kim KS; Jung G; Park YN J Hepatol; 2011 May; 54(5):939-47. PubMed ID: 21145824 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]